A new target for autoantibodies in patients with rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

A new target for autoantibodies in patients with rheumatoid arthritis.

A new target for autoantibodies in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q33300254

about

Carbonic anhydrase III is insufficient in muscles of myasthenia gravis patients.Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.

P2860

Q33419952-AA7CC0B8-7EA9-462B-9C25-761F16A5346B Q33798060-2848A19D-6D8E-4360-BAFF-A8066E6B01C4 Q34975123-8B8F7076-C7F9-4701-BB5A-0F7E572CE65A

P2860

A new target for autoantibodies in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q33300254

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

A new target for autoantibodies in patients with rheumatoid arthritis.

@ast

A new target for autoantibodies in patients with rheumatoid arthritis.

@en

A new target for autoantibodies in patients with rheumatoid arthritis.

@nl

type

label

A new target for autoantibodies in patients with rheumatoid arthritis.

@ast

A new target for autoantibodies in patients with rheumatoid arthritis.

@en

A new target for autoantibodies in patients with rheumatoid arthritis.

@nl

prefLabel

A new target for autoantibodies in patients with rheumatoid arthritis.

@ast

A new target for autoantibodies in patients with rheumatoid arthritis.

@en

A new target for autoantibodies in patients with rheumatoid arthritis.

@nl

P1433

Q33300254-4BA46561-3241-4A63-AE57-F120D88771EA

P1476

Q33300254-884FC5F6-5073-41A8-B78C-37A56957C186

P2093

Q33300254-1E24AB18-F84A-47C7-BA5B-B5C804931C0E

Q33300254-32BAD5AF-EDE4-47F4-B5E1-A750284D14CE

Q33300254-389894B2-4225-44A1-8245-2A5BFFDC6679

Q33300254-AA4E4503-8D5D-48F1-BAE2-DD3EBC9CE549

Q33300254-B7B7620C-5B9C-4276-A365-1D50B9CE4438

Q33300254-B9F5AE92-8F7A-4E6E-9B08-F8B52C96D58E

Q33300254-C8FC468A-6F07-418E-B549-3267DFFE82E9

Q33300254-ED4BEF6B-5571-47BA-B719-8A2B3924F80F

P2860

Q33300254-007CA9B3-4943-429E-BA58-D8B612FE2BCB

Q33300254-05AA3597-9F20-4648-8A57-0DD380DF6046

Q33300254-393F4A12-2C95-46A0-8A07-9E2FF98FA310

Q33300254-3E1DD30A-5DFA-4235-AA95-8290ECFB7C2C

Q33300254-565DFFD4-49B1-4A3E-A83E-9B83D9C93DD9

Q33300254-6A926FC6-9D89-4C12-9AD1-4D45C463F396

Q33300254-79CB4074-6E2E-4F09-B316-67A2D8ADDB8D

Q33300254-7DD28E68-6E6C-44C2-9CF7-AAE670823AF0

Q33300254-8070788A-6955-48DB-92D5-B728509B10C4

Q33300254-9355B01A-A377-4766-97E2-22DC891E2D37

P304

Q33300254-8AB21AB6-0F32-4CC1-AA39-E730B13D5199

P31

Q33300254-91FA7072-AF80-4104-8657-AE5E73126CC0

P356

Q33300254-8AFA89F4-C446-4996-B449-16F034500793

P407

Q33300254-0E13577B-76F8-48A2-9C39-EBADC160B1D4

P478

Q33300254-1365D381-BF11-474E-98C4-8042383FB489

P50

Q33300254-2FBE5674-971A-4016-8FDF-6C3FCF31065C

P577

Q33300254-01792A49-669A-4BB5-9F3D-E1DE4FFEA926

P698

Q33300254-D865FF4E-EF93-4D4F-9747-5E0F9A0B7B09

P921

Q33300254-AACD9A89-16DD-4715-A1DF-89F77FB5C451

P356

ANNALS.1422.039

P1433

Annals of the New York Academy of Sciences

P1476

A new target for autoantibodies in patients with rheumatoid arthritis.

@en

P2093

Agnes Desbos

http://www.w3.org/2001/XMLSchema#string

Annick Moreira

http://www.w3.org/2001/XMLSchema#string

Jacques Bienvenu

http://www.w3.org/2001/XMLSchema#string

Jacques Tebib

http://www.w3.org/2001/XMLSchema#string

Magali Robert-Pachot

http://www.w3.org/2001/XMLSchema#string

Michel Becchi

http://www.w3.org/2001/XMLSchema#string

Nicole Fabien

http://www.w3.org/2001/XMLSchema#string

Tarik Aitsiselmi

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases

Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Characterization of human carbonic anhydrase III from skeletal muscle

Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.

Autoantibodies directed against the amino-terminal domain I of human calpastatin (ACAST-DI Ab) in connective tissue diseases. High levels of ACAST-DI Ab are associated with vasculitis in lupus.

Purification and localization of human carbonic anhydrase. III. Typing of skeletal muscle fibers in paraffin embedded sections.

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients.

P304

382-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1422.039

http://www.w3.org/2001/XMLSchema#string

P407

P478

1108

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17894001

http://www.w3.org/2001/XMLSchema#string

P921